Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > pSivida Signs New Evaluation Agreement

April 5th, 2006

pSivida Signs New Evaluation Agreement

Abstract:
Global bio-nanotech company pSivida Limited (Nasdaq:PSDV)(ASX:PSD)(Xetra:PSI) today announced that it has entered into an evaluation agreement with an undisclosed large medical device company to evaluate cardiovascular delivery of drugs using pSivida's drug delivery technologies.

Source:
businesswire

Bookmark:

Related News Press

Nanomedicine

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013

New Nanopore Sensor Simplifies Analysis of Methylated DNA May 20th, 2013

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Announcements

Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013

Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013

Penn engineers' nanoantennas improve infrared sensing May 20th, 2013

Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013